Literature DB >> 18193271

Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.

Toshishige Shibamoto1, Chiaki Kamikado, Shozo Koyama.   

Abstract

The localization of increased intrahepatic vascular resistance and the segmental vascular responsiveness to endothelin-1 are not well known in liver cirrhosis. We determined the segmental vascular resistances and their response to endothelin-1 of isolated portally perfused bile duct ligation (BDL)-induced cirrhotic rat livers. The portal occlusion pressure (Ppo) and the hepatic venous occlusion pressure (Phvo) were obtained by analyzing the profiles of the portal (Ppv) and hepatic venous (Phv) pressures during the double occlusion maneuver of simultaneous occlusions of the inflow and outflow perfusion lines. From the pressure gradients among Ppv, Ppo, Phvo, and Phv, the portal-hepatic venous resistance was assigned to three segments of the portal [Rpv = (Ppv - Ppo)/blood flow (Q)], sinusoidal [Rsinus = (Ppo - Phvo)/Q] and hepatic venous [Rhv = (Phvo - Phv)/Q] resistances. Rsinus, but not Rpv or Rhv, was significantly greater in BDL livers than in sham livers. Endothelin-1 (0.1-1 nM) increased Rpv and Rsinus to a similar magnitude, but not Rhv, in both sham and BDL. At 3 nM, the responsiveness of Rpv was smaller in BDL than in sham, but that of Rsinus were similar between in BDL and sham. In conclusion, increased sinusoidal resistance accounts for increased intrahepatic resistance of BDL-induced liver cirrhosis. Endothelin-1 contracts portal veins and sinusoids, but not hepatic veins, in both sham and cirrhotic livers. Sinusoidal contractility to endothelin-1 is not impaired in cirrhotic livers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18193271     DOI: 10.1007/s00424-007-0437-6

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  57 in total

1.  Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.

Authors:  H Kojima; J Yamao; T Tsujimoto; M Uemura; A Takaya; H Fukui
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

2.  Therapeutic implications of impaired hepatic oxygen diffusion in chronic liver disease.

Authors:  D J Morgan; A J McLean
Journal:  Hepatology       Date:  1991-12       Impact factor: 17.425

Review 3.  Experimental models of hepatic fibrosis: a review.

Authors:  H Tsukamoto; M Matsuoka; S W French
Journal:  Semin Liver Dis       Date:  1990-02       Impact factor: 6.115

4.  Portal hypertension syndrome. A comparative analysis of bilharzial fibrosis and hepatic cirrhosis.

Authors:  S Beker; J Valencia-Parparcén
Journal:  Am J Dig Dis       Date:  1968-12

5.  Measurement of hepatic blood flow in the rat using fractional clearance of indocyanine green and colloidal radiogold.

Authors:  D Lebrec; L Blanchet; S Lacroix
Journal:  Pflugers Arch       Date:  1981-10       Impact factor: 3.657

6.  Characterization of a reproducible rat model of hepatic veno-occlusive disease.

Authors:  L D DeLeve; R S McCuskey; X Wang; L Hu; M K McCuskey; R B Epstein; G C Kanel
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

7.  Hepatic venous dysregulation contributes to blood volume pooling in cirrhotic rats.

Authors:  Y Li; H Liu; S A Gaskari; D-M McCafferty; S S Lee
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

8.  Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat.

Authors:  H Orrego; L M Blendis; I R Crossley; A Medline; A Macdonald; S Ritchie; Y Israel
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

9.  Functional significance of hepatic arterial flow reserve in patients with cirrhosis.

Authors:  Alexander Zipprich; Norbert Steudel; Curd Behrmann; Frank Meiss; Ursula Sziegoleit; Wolfgang E Fleig; Gerhard Kleber
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

10.  The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver.

Authors:  J Reichen; A L Gerbes; M J Steiner; H Sägesser; M Clozel
Journal:  J Hepatol       Date:  1998-06       Impact factor: 25.083

View more
  2 in total

1.  Embryonic hepatocyte transplantation for hepatic cirrhosis: efficacy and mechanism of action.

Authors:  Wen-Ting Bin; Li-Mei Ma; Qing Xu; Xiao-Lin Shi
Journal:  World J Gastroenterol       Date:  2012-01-28       Impact factor: 5.742

Review 2.  Experimental models of liver fibrosis.

Authors:  Sara Crespo Yanguas; Bruno Cogliati; Joost Willebrords; Michaël Maes; Isabelle Colle; Bert van den Bossche; Claudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Ferreira Alves; Isabelle Leclercq; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2015-06-06       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.